Maryrose P. Sullivan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Smooth | 12 | 2022 | 929 | 1.660 |
Why?
|
Urinary Bladder | 11 | 2020 | 1153 | 1.390 |
Why?
|
Dementia | 8 | 2023 | 2488 | 1.130 |
Why?
|
Urinary Bladder, Overactive | 5 | 2017 | 104 | 1.010 |
Why?
|
Muscle Contraction | 10 | 2022 | 1240 | 0.970 |
Why?
|
Caveolae | 3 | 2012 | 57 | 0.910 |
Why?
|
Fibroins | 6 | 2020 | 55 | 0.880 |
Why?
|
Myenteric Plexus | 1 | 2021 | 40 | 0.800 |
Why?
|
Urodynamics | 8 | 2020 | 342 | 0.700 |
Why?
|
Gastric Fundus | 2 | 2021 | 39 | 0.680 |
Why?
|
Stomach Diseases | 1 | 2019 | 133 | 0.630 |
Why?
|
Gastric Emptying | 1 | 2019 | 232 | 0.600 |
Why?
|
Stomach | 1 | 2021 | 696 | 0.570 |
Why?
|
Urinary Bladder Neck Obstruction | 2 | 2017 | 79 | 0.560 |
Why?
|
Clitoris | 1 | 2015 | 33 | 0.540 |
Why?
|
Coitus | 1 | 2015 | 132 | 0.510 |
Why?
|
Myosin Type V | 1 | 2014 | 34 | 0.480 |
Why?
|
Interstitial Cells of Cajal | 1 | 2013 | 25 | 0.480 |
Why?
|
Muscle Relaxation | 1 | 2014 | 142 | 0.470 |
Why?
|
Neuropilin-2 | 3 | 2022 | 54 | 0.470 |
Why?
|
Caveolin 1 | 2 | 2012 | 264 | 0.470 |
Why?
|
Esophagoplasty | 3 | 2020 | 43 | 0.470 |
Why?
|
Tissue Scaffolds | 6 | 2020 | 952 | 0.460 |
Why?
|
Penis | 1 | 2014 | 207 | 0.440 |
Why?
|
Inosine | 3 | 2018 | 133 | 0.420 |
Why?
|
Caveolins | 1 | 2012 | 104 | 0.420 |
Why?
|
Receptors, Purinergic | 1 | 2012 | 66 | 0.420 |
Why?
|
Myosin Heavy Chains | 1 | 2014 | 416 | 0.420 |
Why?
|
Diabetes Complications | 1 | 2019 | 1356 | 0.420 |
Why?
|
Spinal Cord Injuries | 5 | 2018 | 932 | 0.410 |
Why?
|
Urinary Incontinence | 1 | 2015 | 490 | 0.390 |
Why?
|
Caregivers | 5 | 2023 | 2067 | 0.390 |
Why?
|
Urinary Retention | 1 | 2012 | 110 | 0.390 |
Why?
|
Enteric Nervous System | 1 | 2013 | 184 | 0.380 |
Why?
|
Rural Health Services | 2 | 2007 | 378 | 0.380 |
Why?
|
Regeneration | 5 | 2020 | 1467 | 0.330 |
Why?
|
Synaptic Transmission | 1 | 2013 | 1177 | 0.300 |
Why?
|
Urinary Bladder Diseases | 2 | 2018 | 166 | 0.260 |
Why?
|
Nitric Oxide | 1 | 2014 | 2121 | 0.250 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 1994 | 0.240 |
Why?
|
Wales | 1 | 2023 | 85 | 0.240 |
Why?
|
Geriatric Psychiatry | 1 | 2004 | 70 | 0.240 |
Why?
|
Family Practice | 1 | 2007 | 516 | 0.230 |
Why?
|
Community Mental Health Services | 1 | 2007 | 385 | 0.230 |
Why?
|
Social Support | 3 | 2023 | 2112 | 0.230 |
Why?
|
Community-Institutional Relations | 1 | 2004 | 204 | 0.220 |
Why?
|
England | 1 | 2023 | 522 | 0.210 |
Why?
|
Synaptotagmin II | 1 | 2021 | 15 | 0.210 |
Why?
|
Health Services for the Aged | 1 | 2004 | 268 | 0.200 |
Why?
|
Synaptotagmin I | 1 | 2021 | 36 | 0.200 |
Why?
|
Health Services, Indigenous | 1 | 2002 | 43 | 0.200 |
Why?
|
Urination Disorders | 1 | 2002 | 240 | 0.200 |
Why?
|
Vision Disorders | 2 | 2019 | 1058 | 0.190 |
Why?
|
Gastrointestinal Motility | 1 | 2022 | 224 | 0.190 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 2020 | 11 | 0.190 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5702 | 0.190 |
Why?
|
Angiotensin II | 1 | 2003 | 880 | 0.180 |
Why?
|
Case Management | 1 | 2002 | 287 | 0.180 |
Why?
|
Botulinum Toxins | 1 | 2021 | 191 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 7 | 2018 | 8299 | 0.170 |
Why?
|
Loneliness | 1 | 2021 | 181 | 0.170 |
Why?
|
Silk | 2 | 2020 | 87 | 0.170 |
Why?
|
Urinary Bladder, Neurogenic | 2 | 2018 | 162 | 0.170 |
Why?
|
Animals | 25 | 2022 | 168368 | 0.170 |
Why?
|
Rodentia | 1 | 2020 | 260 | 0.160 |
Why?
|
Renin-Angiotensin System | 1 | 2003 | 763 | 0.160 |
Why?
|
Urethra | 3 | 2007 | 401 | 0.160 |
Why?
|
DNA | 1 | 2012 | 7275 | 0.160 |
Why?
|
Rats | 9 | 2018 | 24270 | 0.160 |
Why?
|
Indians, North American | 1 | 2002 | 352 | 0.160 |
Why?
|
Postprandial Period | 1 | 2019 | 293 | 0.160 |
Why?
|
Benchmarking | 1 | 2004 | 1034 | 0.150 |
Why?
|
Peer Group | 1 | 2022 | 635 | 0.150 |
Why?
|
Tissue Engineering | 3 | 2020 | 1869 | 0.150 |
Why?
|
Gastroparesis | 1 | 2019 | 130 | 0.150 |
Why?
|
Receptor, Adenosine A2A | 1 | 2017 | 124 | 0.140 |
Why?
|
Rural Population | 1 | 2007 | 2181 | 0.140 |
Why?
|
Kidney | 1 | 2012 | 7144 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2634 | 0.130 |
Why?
|
Mucous Membrane | 1 | 2018 | 667 | 0.120 |
Why?
|
Colon | 1 | 2022 | 1771 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12049 | 0.120 |
Why?
|
Nitric Oxide Donors | 1 | 2014 | 121 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 803 | 0.120 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 255 | 0.120 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 170 | 0.110 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18003 | 0.110 |
Why?
|
Aging | 1 | 2012 | 8613 | 0.110 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 647 | 0.110 |
Why?
|
Mental Health Services | 1 | 2004 | 1641 | 0.110 |
Why?
|
Caveolin 3 | 1 | 2012 | 25 | 0.110 |
Why?
|
Rats, Inbred WKY | 1 | 2012 | 158 | 0.110 |
Why?
|
Caveolin 2 | 1 | 2012 | 26 | 0.110 |
Why?
|
Rats, Inbred SHR | 1 | 2012 | 195 | 0.110 |
Why?
|
Laminectomy | 1 | 2013 | 232 | 0.100 |
Why?
|
Evoked Potentials | 1 | 2018 | 1057 | 0.100 |
Why?
|
Swine | 5 | 2020 | 5901 | 0.100 |
Why?
|
Ureter | 2 | 2004 | 361 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 265 | 0.100 |
Why?
|
Esophagus | 1 | 2017 | 1017 | 0.100 |
Why?
|
Spinal Cord Compression | 1 | 2013 | 237 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2019 | 1357 | 0.090 |
Why?
|
Signal Transduction | 2 | 2012 | 23355 | 0.090 |
Why?
|
Kidney Function Tests | 1 | 2012 | 681 | 0.090 |
Why?
|
Hospitals | 1 | 2022 | 3916 | 0.080 |
Why?
|
Humans | 26 | 2023 | 739398 | 0.080 |
Why?
|
Isometric Contraction | 2 | 2018 | 147 | 0.070 |
Why?
|
Male | 16 | 2020 | 349022 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1967 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2768 | 0.070 |
Why?
|
Ontario | 1 | 2007 | 375 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 13002 | 0.070 |
Why?
|
Models, Biological | 2 | 2017 | 9609 | 0.070 |
Why?
|
Blood Glucose | 1 | 2019 | 6237 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 346 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5181 | 0.060 |
Why?
|
Mice | 6 | 2022 | 81002 | 0.060 |
Why?
|
Population Dynamics | 1 | 2004 | 300 | 0.050 |
Why?
|
Carbachol | 1 | 2022 | 226 | 0.050 |
Why?
|
New Mexico | 1 | 2002 | 86 | 0.050 |
Why?
|
Arizona | 1 | 2002 | 106 | 0.050 |
Why?
|
Self-Help Groups | 1 | 2023 | 188 | 0.050 |
Why?
|
Mentors | 1 | 2007 | 632 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2018 | 5721 | 0.050 |
Why?
|
Medicine, Traditional | 1 | 2002 | 90 | 0.050 |
Why?
|
Losartan | 1 | 2003 | 284 | 0.050 |
Why?
|
Urinary Incontinence, Stress | 1 | 2003 | 182 | 0.050 |
Why?
|
Urinary Tract Infections | 1 | 2007 | 766 | 0.050 |
Why?
|
rho-Associated Kinases | 2 | 2012 | 279 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4400 | 0.050 |
Why?
|
Needs Assessment | 1 | 2007 | 1145 | 0.050 |
Why?
|
Interprofessional Relations | 1 | 2007 | 1008 | 0.050 |
Why?
|
Long-Term Care | 1 | 2004 | 606 | 0.050 |
Why?
|
Alzheimer Disease | 2 | 2019 | 7975 | 0.050 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 417 | 0.050 |
Why?
|
Qualitative Research | 2 | 2019 | 2656 | 0.040 |
Why?
|
Urinary Tract | 1 | 2002 | 301 | 0.040 |
Why?
|
Canada | 1 | 2004 | 2021 | 0.040 |
Why?
|
Gene Expression | 1 | 2012 | 7788 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 28901 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21863 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 361 | 0.040 |
Why?
|
Nurse Practitioners | 1 | 2002 | 270 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 2018 | 109 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2003 | 1769 | 0.040 |
Why?
|
Life Change Events | 1 | 2023 | 936 | 0.040 |
Why?
|
Caustics | 1 | 2017 | 29 | 0.040 |
Why?
|
Abdomen | 1 | 2004 | 1104 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 2018 | 156 | 0.040 |
Why?
|
Female | 11 | 2020 | 378853 | 0.040 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2017 | 48 | 0.040 |
Why?
|
Pressure | 3 | 2007 | 1201 | 0.040 |
Why?
|
Xanthines | 1 | 2017 | 121 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1997 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 625 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 141 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4743 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 2018 | 398 | 0.030 |
Why?
|
Triazines | 1 | 2017 | 316 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18349 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2164 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19811 | 0.030 |
Why?
|
Education, Medical | 1 | 2007 | 1712 | 0.030 |
Why?
|
Health Care Reform | 1 | 2004 | 1258 | 0.030 |
Why?
|
Prostatectomy | 1 | 2003 | 1858 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2012 | 57650 | 0.030 |
Why?
|
Aged | 5 | 2018 | 162698 | 0.030 |
Why?
|
Psychiatry | 1 | 2007 | 1686 | 0.030 |
Why?
|
Focus Groups | 1 | 2019 | 1308 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2015 | 234 | 0.030 |
Why?
|
Potassium Channels | 1 | 2017 | 563 | 0.030 |
Why?
|
Neurofilament Proteins | 1 | 2015 | 316 | 0.030 |
Why?
|
Pilot Projects | 1 | 2007 | 8275 | 0.030 |
Why?
|
Bombyx | 1 | 2013 | 55 | 0.030 |
Why?
|
Psychometrics | 1 | 2022 | 2995 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1571 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2022 | 14558 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2015 | 426 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1310 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 956 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4158 | 0.020 |
Why?
|
Urothelium | 1 | 2013 | 277 | 0.020 |
Why?
|
Triazoles | 1 | 2017 | 906 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 375 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 241 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2013 | 277 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2018 | 2533 | 0.020 |
Why?
|
Sus scrofa | 1 | 2012 | 437 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 12640 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 563 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2003 | 11347 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3203 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2021 | 76631 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2480 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11699 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 682 | 0.020 |
Why?
|
Middle Aged | 3 | 2018 | 212863 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1934 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15153 | 0.020 |
Why?
|
Latex | 1 | 2007 | 52 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 2004 | 0.020 |
Why?
|
Compliance | 1 | 2007 | 105 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2564 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2012 | 1181 | 0.020 |
Why?
|
Family | 1 | 2018 | 3141 | 0.020 |
Why?
|
Metformin | 1 | 2012 | 827 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 6963 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1730 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1675 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2999 | 0.020 |
Why?
|
Mental Disorders | 1 | 2004 | 6570 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 2757 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5959 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3065 | 0.010 |
Why?
|
Viscosity | 1 | 2004 | 328 | 0.010 |
Why?
|
Intestines | 1 | 2012 | 1919 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4205 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2007 | 690 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2007 | 522 | 0.010 |
Why?
|
Adult | 3 | 2007 | 213394 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8274 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3036 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 643 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 24714 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4463 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2004 | 1682 | 0.010 |
Why?
|
Linear Models | 1 | 2007 | 5948 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 85405 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7862 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5113 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15036 | 0.000 |
Why?
|
Algorithms | 1 | 2007 | 13872 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2003 | 6318 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 10999 | 0.000 |
Why?
|